MedPath

Therapeutic effect of Topiramate in refractory Obsessive Compulsive Disorder

Not Applicable
Conditions
Obcessive Compulsive Disorder.
Obsessive Compulsive Disorder
Registration Number
IRCT2013012312252N1
Lead Sponsor
Isfahan University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
32
Inclusion Criteria

Obsessive Compulsive criteria according to DSM-IV-TR;
Be used maximum tolerated dose of SSRI or Clomipramine for at least 12 weeks;
moderate to severe symptoms according to Yale Brown Scale score more than 16;
informed consent
Exclusion criteria:primary diagnosis of psychotic or mood disorder(bipolar or MDD); subtance abuse or dependence; uncontrolled medical illness(e.g. DM,HTN,...); previous use of Topiramate; pregnancy or breastfeeding or who wants to be pregnant; convulsive disorder; suicidal thought; past history of renal stone

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Obsessive Compulsive Disorder severity. Timepoint: before intervention and after first,second and third month. Method of measurement: Yale Brown Scale and CGI scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath